Ignite Creation Date:
2024-05-06 @ 12:46 AM
Last Modification Date:
2024-10-26 @ 10:54 AM
Study NCT ID:
NCT01658436
Status:
COMPLETED
Last Update Posted:
2016-05-02
First Post:
2012-07-06
Brief Title:
BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors pNET After Failure of mTOR Inhibitor Therapy
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-06
First Submit QC Date:
August 6 2012
Study First Post Date:
2012-08-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-05-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-04-19
Last Update Post Date:
2016-05-02
Last Update Post Date Type:
ESTIMATED